Maurizio Romagnuolo
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Real-world effectiveness of topical ruxolitinib in non-segmental vitiligo: repigmentation, mental health, and quality-of-life outcomes in an 860-patient multicentre study.
Journal: The British journal of dermatology
Published: May 16, 2026
Editorial: Exploring cutaneous drug-related and drug-associated adverse events: from clinical insight to therapeutic management.
Journal: Frontiers in medicine
Published: May 09, 2026
Type I and II Interferon Signalling Characterizes the Transcriptional Landscape of Sweet Syndrome.
Journal: Experimental dermatology
Published: March 02, 2026
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.
Journal: Acta dermato-venereologica
Published: January 09, 2026
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.
Journal: Acta dermato-venereologica
Published: January 09, 2026
Editorial: Genetics and epigenetics of melanoma and non-melanoma skin cancer.
Journal: Frontiers in genetics
Published: December 18, 2025
Tinea barbae following ruxolitinib cream application in a vitiligo patient: a case report.
Journal: Frontiers in medicine
Published: December 11, 2025
The Multifaceted Role of Keratinocytes in Hidradenitis Suppurativa Pathogenesis.
Journal: Experimental dermatology
Published: November 19, 2025
Real-Life Perception of Treatment Effectiveness After 24 Weeks of Topical Ruxolitinib in Non-Segmental Vitiligo: Insights From Patient-Reported Outcomes.
Journal: International journal of dermatology
Published: October 10, 2025
Role of the interleukin-15 pathway in vitiligo: Mechanistic insights and therapeutic implications.
Journal: The Journal of investigative dermatology
Published: July 27, 2025
Role of the IL-15 pathway in vitiligo: Mechanistic insights and therapeutic implications.
Journal: The Journal of investigative dermatology
Published: July 27, 2025
The Role of Cutaneous B-Cells in Hidradenitis Suppurativa: From Preclinical Evidence to Novel Targeted Therapies.
Journal: Experimental dermatology
Published: March 28, 2025
Last Updated: 09/26/2026